Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUDYT: Deutetrabenazine in Adult Dystonia
NCT04173260Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deutetrabenazine in primary dystonia, sponsored by University of Pennsylvania. Started Apr 2021; status: completed.
02
Drugs
deutetrabenazine
03
Conditions
primary dystonia
Beyond the preview
Go deeper on NCT04173260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173260.